Skip to main content
SpringerLink
Log in

Elabela Peptide: A New Player in Hypertension and Vascular Damage

  • Commentary
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Corrigendum to. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;40:475.

    Google Scholar 

  2. Xu J, Chen L, Jiang Z, Li L. Biological functions of Elabela, a novel endogenous ligand of APJ receptor. J Cell Physiol. 2018;233:6472–82.

    Article  CAS  Google Scholar 

  3. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A. 2004;101:10464–9.

    Article  Google Scholar 

  4. Zhou M, Wu Y. Effects and signaling pathways of Elabela in the cardiovascular system. Peptides. 2022;147:170674.

    Article  CAS  Google Scholar 

  5. Sato T, Sato C, Kadowaki A, Watanabe H, Ho L, Ishida J, et al. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovasc Res. 2017;113:760–9.

    Article  CAS  Google Scholar 

  6. Geng Z, Ye C, Tong Y, Zhang F, Zhou YB, Xiong XQ. Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2020;318:H124–34.

    Article  CAS  Google Scholar 

  7. Li Y, Yang X, Ouyang S, He J, Yu B, Lin X, et al. Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: a preliminary study. Clin Exp Hypertens. 2020;42:239–43.

    Article  CAS  Google Scholar 

  8. Diakowska D, Wyderka R, Krzystek-Korpacka M, Osuch Ł, Leśków A, Sołtowska A, et al. Plasma levels of Apelinergic system components in patients with chronic and acute coronary syndromes—a pilot study. J Clin Med. 2021;10:4420.

    Article  CAS  Google Scholar 

  9. Dindas F, Koyuncu I, Ocek L, Ozdemir AV, Yılmaz H, Abacıoglu OO, et al. Association of serum elabela levels with carotid artery stenosis in patients with non-cardioembolic ischemic stroke. Biomark Med. 2022;16:623–31.

    Article  CAS  Google Scholar 

  10. Suko-Adiarto H, Prakoso R, Firdaus I, Indriani S, Rudiktyo E, Widyantoro B, et al. A novel peptide elabela is associated with hypertension-related subclinical atherosclerosis. Current issue of the journal.

  11. Øygarden H. Carotid intima-media thickness and prediction of cardiovascular disease. J Am Heart Assoc. 2017;6:e005313.

    Article  Google Scholar 

Download references

Funding

No fundings were provided for this work.

Author information

Authors and Affiliations

  1. Department of Clinical and Molecular Medicine, School of Medicine and Psychology , Sapienza University of Rome , Rome, Italy

    Speranza Rubattu

  2. IRCCS Neuromed, Pozzilli, IS, Italy

    Speranza Rubattu

Authors
  1. Speranza Rubattu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Speranza Rubattu.

Ethics declarations

Conflict of interest

There are no conflicts of interest to disclose.

Ethical statement

Not applicable.

Additional information

Commentary to “A Novel Peptide Elabela is Associated with Hypertension-Related Subclinical Atherosclerosis”.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rubattu, S. Elabela Peptide: A New Player in Hypertension and Vascular Damage. High Blood Press Cardiovasc Prev 30, 5–6 (2023). https://doi.org/10.1007/s40292-022-00556-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40292-022-00556-z

Search

Navigation